文献速递冠心病血脂与心血管预防

PROMISE研究:冠状动脉钙化在稳定性胸痛患者中的预后价值

Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).
PubMed 文献 · Circulation · 2017-08-28

PROMISE试验纳入稳定性胸痛或呼吸困难且冠心病验前概率中等的患者,随机接受功能学检查或解剖学检查,其中4209例接受CAC评分、4602例接受功能学检查。中位随访26.1个月,CAC和功能学检查对主要终点(全因死亡、心肌梗死或不稳定型心绞痛住院)的预测能力相似(C统计量0.67 vs 0.64),但功能学检查异常对事件的特异性更高。

要点

  • 中重度CAC异常和功能学检查异常均能独立预测心血管事件。
  • 84%的事件发生在CAC>0的患者中,而功能学检查异常者仅占事件的43%。
  • 功能学检查异常对事件的特异性(78.6%)显著高于CAC(35.2%)。

核心结论

  • 在稳定性胸痛门诊患者中,多数发生临床事件的患者基线CAC可测得,而不足半数功能学检查异常。
  • 功能学检查异常对心血管事件特异性更高,但两种检查整体判别能力相似且中等。

研究设计与样本

  • PROMISE试验为多中心随机对照研究,稳定性胸痛或呼吸困难且冠心病验前概率中等的患者随机接受功能学检查或解剖学检查。
  • 本次分析纳入接受CAC检查者4209例和功能学检查者4602例,中位随访26.1个月。

主要发现

  • CAC与功能学检查结果分布显著不同(P<0.0001):CAC正常34.6%、轻度31.8%、中度18.3%、重度15.2%;功能学检查正常78.0%、轻度9.4%、中度4.7%、重度7.9%。
  • 中度异常预测事件:CAC的HR为3.14(95%CI 1.81-5.44),功能学检查的HR为2.65(95%CI 1.46-4.83)。
  • 重度异常预测事件:CAC的HR为3.56(95%CI 1.99-6.36),功能学检查的HR为3.88(95%CI 2.58-5.85)。
  • CAC组84%(112/133)的事件发生于CAC>0者,功能学检查组仅43%(57/132)的事件发生于任何异常者(P<0.001)。
  • 功能学检查任何异常对事件的特异性为78.6%,显著高于CAC的35.2%(P<0.001);整体C统计量CAC为0.67、功能学检查为0.64,冠状动脉CT血管造影为0.72。

临床怎么用

  • 对于稳定性胸痛且验前概率中等的患者,CAC>0可识别出多数未来发生事件者,但特异性较低。
  • 功能学检查异常对事件特异性更高,临床可结合两者优势进行风险分层。

局限性

  • PROMISE试验为随机对照设计,但本分析为对接受CAC或功能学检查亚组的比较,可能存在选择偏倚。
  • 中位随访仅26.1个月,长期预后价值需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronary artery calcium (CAC) is an established predictor of future major adverse atherosclerotic cardiovascular events in asymptomatic individuals. However, limited data exist as to how CAC compares with functional testing (FT) in estimating prognosis in symptomatic patients. METHODS: In the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain), patients with stable chest pain (or dyspnea) and intermediate pretest probability for obstructive coronary artery disease were randomized to FT (exercise electrocardiography, nuclear stress, or stress echocardiography) or anatomic testing. We evaluated those who underwent CAC testing as part of the anatomic evaluation (n=4209) and compared that with results of FT (n=4602). We stratified CAC and FT results as normal or mildly, moderately, or severely abnormal (for CAC: 0, 1-99 Agatston score [AS], 100-400 AS, and >400 AS, respectively; for FT: normal, mild=late positive treadmill, moderate=early positive treadmill or single-vessel ischemia, and severe=large ischemic region abnormality). The primary end point was all-cause death, myocardial infarction, or unstable angina hospitalization over a median follow-up of 26.1 months. Cox regression models were used to calculate hazard ratios (HRs) and C statistics to determine predictive and discriminatory values. RESULTS: Overall, the distribution of normal or mildly, moderately, or severely abnormal test results was significantly different between FT and CAC (FT: normal, n=3588 [78.0%]; mild, n=432 [9.4%]; moderate, n=217 [4.7%]; severe, n=365 [7.9%]; CAC: normal, n=1457 [34.6%]; mild, n=1340 [31.8%]; moderate, n=772 [18.3%]; severe, n=640 [15.2%]; P<0.0001). Moderate and severe abnormalities in both arms robustly predicted events (moderate: CAC: HR, 3.14; 95% confidence interval, 1.81-5.44; and FT: HR, 2.65; 95% confidence interval, 1.46-4.83; severe: CAC: HR, 3.56; 95% confidence interval, 1.99-6.36; and FT: HR, 3.88; 95% confidence interval, 2.58-5.85). In the CAC arm, the majority of events (n=112 of 133, 84%) occurred in patients with any positive CAC test (score >0), whereas fewer than half of events occurred in patients with mildly, moderately, or severely abnormal FT (n=57 of 132, 43%; P<0.001). In contrast, any abnormality on FT was significantly more specific for predicting events (78.6% for FT versus 35.2% for CAC; P<0.001). Overall discriminatory ability in predicting the primary end point of mortality, nonfatal myocardial infarction, and unstable angina hospitalization was similar and fair for both CAC and FT (C statistic, 0.67 versus 0.64). Coronary computed tomographic angiography provided significantly better prognostic information compared with FT and CAC testing (C index, 0.72). CONCLUSIONS: Among stable outpatients presenting with suspected coronary artery disease, most patients experiencing clinical events have measurable CAC at baseline, and fewer than half have any abnormalities on FT. However, an abnormal FT was more specific for cardiovascular events, leading to overall similarly modest discriminatory abilities of both tests. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01174550.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Budoff MJ, Mayrhofer T, Ferencik M, et al. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation. 2017. PMID: 28847895. doi:10.1161/CIRCULATIONAHA.117.030578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。